Trademark: 79320193
Status Date
Monday, September 25, 2023
Filing Date
Thursday, February 25, 2021
9 Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; none of the foregoing in connection with HVAC systems or components thereof
35 Compilation of statistical data and models with respect to cancer treatment and cancer diagnosis
44 Medical and pharmaceutical consultancy services
42 Computer programming in the medical, pharmaceutical and biotechnological field; database design in the medical, pharmaceutical and biotechnological field; maintenance of database software in the medical, pharmaceutical, and biotechnological field; programming of software for importing and managing data in the medical, pharmaceutical, and biotechnological field; information technology [IT] consulting services for the pharmaceutical and healthcare industries; computer programming for data processing; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; providing scientific molecular and genomic information for medical and clinical research, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology; none of the foregoing in connection with HVAC systems or components thereof
Mar 29, 2024
Suspension Checked - To Attorney For Action
Mar 29, 2024
Assigned To Examiner
Mar 25, 2024
Suspension Checked - To Attorney For Action
Sep 25, 2023
Report Completed Suspension Check Case Still Suspended
Mar 14, 2023
Notification Of Possible Opposition - Processed By Ib
Feb 27, 2023
Report Completed Suspension Check Case Still Suspended
Feb 22, 2023
Notification Of Possible Opposition Sent To Ib
Feb 22, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 30, 2023
Teas/Email Correspondence Entered
Jan 30, 2023
Correspondence Received In Law Office
Jan 30, 2023
Teas Response To Suspension Inquiry Received
Nov 28, 2022
Report Completed Suspension Check Case Still Suspended
Nov 2, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 2, 2022
Teas Change Of Correspondence Received
Nov 2, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 2, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 2, 2022
Teas Change Of Owner Address Received
Oct 7, 2022
New Representative At Ib Received
May 13, 2022
Notification Of Letter Of Suspension E-Mailed
May 13, 2022
Letter Of Suspension E-Mailed
May 13, 2022
Suspension Letter Written
May 12, 2022
Teas/Email Correspondence Entered
May 12, 2022
Correspondence Received In Law Office
May 10, 2022
Assigned To Lie
May 6, 2022
Teas Response To Suspension Inquiry Received
Nov 29, 2021
Refusal Processed By Ib
Nov 8, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Nov 8, 2021
Refusal Processed By Mpu
Oct 14, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Oct 13, 2021
Suspension Letter Written
Oct 7, 2021
Non-Final Action (Ib Refusal) Withdrawn For Review
Sep 24, 2021
Application Filing Receipt Mailed
Sep 22, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Sep 21, 2021
Suspension Letter Written
Sep 21, 2021
Assigned To Examiner
Sep 20, 2021
New Application Office Supplied Data Entered
Sep 16, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
